Literature DB >> 19014877

Settling the "score" with liver cancer.

Christopher Koh, T Jake Liang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19014877      PMCID: PMC2676232          DOI: 10.1016/j.jhep.2008.10.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  16 in total

1.  Hepatitis B e Antigen--the dangerous endgame of hepatitis B.

Authors:  T Jake Liang; Marc Ghany
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

Review 2.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.

Authors:  Man-Fung Yuen; Yasuhito Tanaka; Daniel Yee-Tak Fong; James Fung; Danny Ka-Ho Wong; John Chi-Hang Yuen; David Yiu-Kuen But; Annie On-On Chan; Benjamin Chun-Yu Wong; Masashi Mizokami; Ching-Lung Lai
Journal:  J Hepatol       Date:  2008-09-21       Impact factor: 25.083

Review 4.  Hepatitis B virus. The major etiology of hepatocellular carcinoma.

Authors:  R P Beasley
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

5.  Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas.

Authors:  S N Zaman; P J Johnson; R Williams
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

6.  Hepatitis B e antigen and the risk of hepatocellular carcinoma.

Authors:  Hwai-I Yang; Sheng-Nan Lu; Yun-Fan Liaw; San-Lin You; Chien-An Sun; Li-Yu Wang; Chuhsing K Hsiao; Pei-Jer Chen; Ding-Shinn Chen; Chien-Jen Chen
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

7.  Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis.

Authors:  G Fattovich; G Giustina; S W Schalm; S Hadziyannis; J Sanchez-Tapias; P Almasio; E Christensen; K Krogsgaard; F Degos; M Carneiro de Moura
Journal:  Hepatology       Date:  1995-01       Impact factor: 17.425

Review 8.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

Authors:  D Lavanchy
Journal:  J Viral Hepat       Date:  2004-03       Impact factor: 3.728

Review 9.  Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

10.  Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.

Authors:  Hwai-I Yang; Shiou-Hwei Yeh; Pei-Jer Chen; Uchenna H Iloeje; Chin-Lan Jen; Jun Su; Li-Yu Wang; Sheng-Nan Lu; San-Lin You; Ding-Shinn Chen; Yun-Fan Liaw; Chien-Jen Chen
Journal:  J Natl Cancer Inst       Date:  2008-08-11       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.